Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 94 articles: HTML format

Single Articles

June 2025
1. FUJIMOTO D, Kinoshita D, Suzuki K, Niida T, et al
   Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina.
   Atherosclerosis. 2025;405:119237.
   PubMed     Abstract available
   
   
   May 2025
2. ELIAS-LOPEZ D, Kobylecki CJ, Vedel-Krogh S, Doi T, et al
   Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function.
   Atherosclerosis. 2025;406:119241.
   PubMed     Abstract available
   
   
   
3. SUZUKI T, Haberlen S, Peterson TE, Palella F, et al
   Coronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study.
   Atherosclerosis. 2025;404:119181.
   PubMed     Abstract available
   
   
   
4. CONTE E, Lee SE, Chang HJ, Hadamitzky M, et al
   Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study.
   Atherosclerosis. 2025;404:119184.
   PubMed     Abstract available
   
   
   April 2025
5. SANTOS RD, Ray KK, De Bacquer D, Jennings C, et al
   Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE.
   Atherosclerosis. 2025;405:119215.
   PubMed     Abstract available
   
   
   
6. TADA H, Nohara A, Usui S, Sakata K, et al
   Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.
   Atherosclerosis. 2025;404:119185.
   PubMed     Abstract available
   
   
   
7. FAROOQ S, Generoso G, Bensenor IM, Santos RD, et al
   Low-density lipoprotein-cholesterol subfractions as predictors for coronary artery calcium incidence and progression - The Brazilian longitudinal study of Adult Health (ELSA - Brasil).
   Atherosclerosis. 2025;403:119171.
   PubMed     Abstract available
   
   
   
8. PIVORIUNAS J, Engebretsen I, Vethe NT, Kristiansen O, et al
   Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data.
   Atherosclerosis. 2025;403:119138.
   PubMed     Abstract available
   
   
   
9. YUAN X, Zhang L, Li X, Chen K, et al
   Differential lipid impact on mortality in patients undergoing CABG versus PCI.
   Atherosclerosis. 2025;403:119141.
   PubMed     Abstract available
   
   
   
10. FUJINO M, Di Giovanni G, Butters Bhsc J, Kataoka Y, et al
    Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS.
    Atherosclerosis. 2025;403:119145.
    PubMed     Abstract available
    
    
    
11. ZHANG P, Wang W, Xu Q, Cui J, et al
    Genetic association of circulating lipids and lipid-lowering drug targets with vascular calcification.
    Atherosclerosis. 2025;403:119136.
    PubMed     Abstract available
    
    
    March 2025
12. RIKHI R, Haidar A, Bhatia HS, Beam K, et al
    Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2025;404:119179.
    PubMed     Abstract available
    
    
    
13. SADLER M, Cannata A, Mackie S, Mondi Anandhakrishna R, et al
    Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction.
    Atherosclerosis. 2025;403:119169.
    PubMed     Abstract available
    
    
    
14. MOK Y, Ballew SH, Schrack JA, Howard CM, et al
    Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2025;402:119115.
    PubMed     Abstract available
    
    
    
15. YABUMOTO N, Fujino M, Sugane H, Hosoda H, et al
    Clinical implications of calcification severity adjacent to calcified nodule: Its association with first and recurrent risks of target lesion revascularization after percutaneous coronary intervention.
    Atherosclerosis. 2025;402:119116.
    PubMed     Abstract available
    
    
    
16. ZHENG N, Liu Z, Ding Y, Wang X, et al
    Incremental prognostic value of pericoronary adipose tissue attenuation beyond conventional features in patients with nonobstructive coronary artery disease.
    Atherosclerosis. 2025;402:119075.
    PubMed     Abstract available
    
    
    February 2025
17. ZHANG Y, Wu J, Wang N, Zhu J, et al
    Global burden and national health inequity of ischemic heart disease attributed to kidney dysfunction from 1990 to 2021: Findings from the global burden of disease study 2021.
    Atherosclerosis. 2025 Feb 26:119140. doi: 10.1016/j.atherosclerosis.2025.119140.
    PubMed     Abstract available
    
    
    
18. KRUGER A, Willems van Dijk K, van Heemst D, Noordam R, et al
    Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.
    Atherosclerosis. 2025;403:119135.
    PubMed     Abstract available
    
    
    
19. CHIGNON A, Lettre G
    Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease.
    Atherosclerosis. 2025;401:118621.
    PubMed     Abstract available
    
    
    
20. TUFARO V, Torii R, Aben JP, Parasa R, et al
    Can fast wall shear stress computation predict adverse cardiac events in patients with intermediate non-flow limiting stenoses?
    Atherosclerosis. 2025;401:119099.
    PubMed     Abstract available
    
    
    
21. YI B, He L, Zhang D, Zeng M, et al
    Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes.
    Atherosclerosis. 2025;401:119092.
    PubMed     Abstract available
    
    
    
22. RAZIPOUR A, Grodecki K, Manral N, Geers J, et al
    AI-derived automated quantification of cardiac chambers and myocardium from non-contrast CT: Prediction of major adverse cardiovascular events in asymptomatic subjects.
    Atherosclerosis. 2025;401:119098.
    PubMed     Abstract available
    
    
    
23. GIBSON K, Forrest IS, Petrazzini BO, Duffy A, et al
    Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.
    Atherosclerosis. 2025;401:119103.
    PubMed     Abstract available
    
    
    
24. MANIKPURAGE HD, Ricard J, Houessou U, Bourgault J, et al
    Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.
    Atherosclerosis. 2025;401:119083.
    PubMed     Abstract available
    
    
    
25. DREXEL H, Mader A, Larcher B, Festa A, et al
    Remnant cholesterol and long-term incidence of death in coronary artery disease patients.
    Atherosclerosis. 2025;401:119048.
    PubMed     Abstract available
    
    
    January 2025
26. ARAUNA D, Chandia E, Nova-Lamperti E, Radojkovic C, et al
    Platelet Content from Acute Myocardial Infarction Patients: Elevated Levels of IL-6 and IL-8 and their impact on Endothelial Nitric Oxide Production.
    Atherosclerosis. 2025;403:119119.
    PubMed     Abstract available
    
    
    December 2024
27. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Myocardial infarction in second-generation immigrants compared to native-born Swedes in the total population of Sweden.
    Atherosclerosis. 2024 Dec 26:119102. doi: 10.1016/j.atherosclerosis.2024.119102.
    PubMed     Abstract available
    
    
    
28. KYHL LK, Nordestgaard BG, Tybjaerg-Hansen A, Smith GD, et al
    VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction.
    Atherosclerosis. 2024;401:119094.
    PubMed     Abstract available
    
    
    
29. JUHASZ V, Charlier FT, Zhao TX, Tsiantoulas D, et al
    Targeting the adaptive immune continuum in atherosclerosis and post-MI injury.
    Atherosclerosis. 2024;399:118616.
    PubMed     Abstract available
    
    
    
30. KATAOKA T, Morishita T, Uzui H, Sato Y, et al
    Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study.
    Atherosclerosis. 2024;399:118581.
    PubMed     Abstract available
    
    
    November 2024
31. MENG Q, Zhao L, Zhao N, An Y, et al
    Progression of coronary artery calcium density and major adverse cardiovascular events.
    Atherosclerosis. 2024;398:118593.
    PubMed     Abstract available
    
    
    
32. KLUNER LV, Chan K, Antoniades C
    Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature.
    Atherosclerosis. 2024;398:117580.
    PubMed     Abstract available
    
    
    
33. LEIVA O, Zhou S, How J, Lee M, et al
    Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms.
    Atherosclerosis. 2024;401:119046.
    PubMed     Abstract available
    
    
    October 2024
34. SIMONY SB, Langsted A, Mortensen MB, Nordestgaard BG, et al
    Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study.
    Atherosclerosis. 2024;399:118625.
    PubMed     Abstract available
    
    
    
35. HAGAN K, Mszar R, Cainzos-Achirica M, Blaha MJ, et al
    Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida.
    Atherosclerosis. 2024;397:118551.
    PubMed     Abstract available
    
    
    
36. KILBO EDLUND K, Andersson EM, Asker C, Barregard L, et al
    Long-term ambient air pollution and coronary atherosclerosis: Results from the Swedish SCAPIS study.
    Atherosclerosis. 2024;397:117576.
    PubMed     Abstract available
    
    
    
37. GUGLIELMO M, Penso M, Carerj ML, Giacari CM, et al
    DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR.
    Atherosclerosis. 2024;397:117549.
    PubMed     Abstract available
    
    
    September 2024
38. ALDUJELI A, Tsai TY, Haq A, Tatarunas V, et al
    The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2024;398:118597.
    PubMed     Abstract available
    
    
    
39. VALLEJO-VAZ AJ, Dharmayat KI, Nzeakor N, Carrasco CP, et al
    Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study.
    Atherosclerosis. 2024;398:118589.
    PubMed     Abstract available
    
    
    
40. QIU J, Fu Y, Tian T, Mao Y, et al
    Suppression of FOXC1 induces pyroptosis of the coronary artery through activation of JAK2.
    Atherosclerosis. 2024;396:118543.
    PubMed     Abstract available
    
    
    August 2024
41. EYRICH TM, Dalila N, Christoffersen M, Tybjaerg-Hansen A, et al
    Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
    Atherosclerosis. 2024;397:118574.
    PubMed     Abstract available
    
    
    
42. VOLLEBERG RHJA, Mol JQ, Belkacemi A, Hermanides RS, et al
    Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
    Atherosclerosis. 2024;397:118568.
    PubMed     Abstract available
    
    
    
43. VAISAR T, Babenko I, Horvath KV, Niisuke K, et al
    Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
    Atherosclerosis. 2024;397:118565.
    PubMed     Abstract available
    
    
    
44. CHEN JX, Lu Q, Geng T, Wang Y, et al
    Differences in HDL-related coronary heart disease risk between individuals with and without diabetes.
    Atherosclerosis. 2024;397:118553.
    PubMed     Abstract available
    
    
    
45. TRAMUJAS L, Nogueira A, Felix N, de Barros E Silva PGM, et al
    Association of colchicine use with cardiovascular and limb events in peripheral artery disease: Insights from a retrospective cohort study.
    Atherosclerosis. 2024 Aug 9:118563. doi: 10.1016/j.atherosclerosis.2024.118563.
    PubMed     Abstract available
    
    
    
46. QI X, Zhang Y, Wang Y, Sun J, et al
    Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
    Atherosclerosis. 2024;395:117552.
    PubMed     Abstract available
    
    
    
47. WENTZEL JJ, Bos D, White SJ, van der Heiden K, et al
    Sex-related differences in coronary and carotid vessel geometry, plaque composition and shear stress obtained from imaging.
    Atherosclerosis. 2024;395:117616.
    PubMed     Abstract available
    
    
    
48. PATEL NH, Dave EK, Fatade YA, De Cecco CN, et al
    Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
    Atherosclerosis. 2024;395:118520.
    PubMed     Abstract available
    
    
    
49. MIRANDA MARAVI JS, Leszczynski EC, Schwartz CS, Dev PK, et al
    Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.
    Atherosclerosis. 2024;395:117587.
    PubMed     Abstract available
    
    
    
50. ZHANG J, Zhong Q, Lin Y, Zhang Y, et al
    Longitudinal albuminuria patterns predict coronary artery calcification progression: Findings from the Coronary Artery Risk Development in Young Adults study.
    Atherosclerosis. 2024;395:117574.
    PubMed     Abstract available
    
    
    
51. FERRARO B
    The SR-B1DeltaCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
    Atherosclerosis. 2024;395:117564.
    PubMed    
    
    
    
52. HOSHINO M, Jukema RA, Pijls N, Hoek R, et al
    Microvascular resistance reserve before and after PCI: A serial FFR and [(15)O] H(2)O PET study.
    Atherosclerosis. 2024;395:117555.
    PubMed     Abstract available
    
    
    
53. PARK CH, Kim HW, Park JT, Chang TI, et al
    Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study.
    Atherosclerosis. 2024;395:117563.
    PubMed     Abstract available
    
    
    
54. MULLIS DM, Padilla-Lopez A, Wang H, Zhu Y, et al
    Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT/LDLR KO mouse.
    Atherosclerosis. 2024;395:117518.
    PubMed     Abstract available
    
    
    
55. OLIVEIRA-SANTOS M, Borges-Rosa J, Silva R, Paixao L, et al
    Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT.
    Atherosclerosis. 2024;395:117481.
    PubMed     Abstract available
    
    
    July 2024
56. HUANG H, Liu J, Li Q, Qiao L, et al
    Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation.
    Atherosclerosis. 2024;394:117306.
    PubMed     Abstract available
    
    
    June 2024
57. BEN-SHABAT N, Krasun A, Fisher L, Patt YS, et al
    Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study.
    Atherosclerosis. 2024;396:117626.
    PubMed     Abstract available
    
    
    
58. IBRAHIM S, Hartgers ML, Reeskamp LF, Zuurbier L, et al
    LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.
    Atherosclerosis. 2024 Jun 10:117610. doi: 10.1016/j.atherosclerosis.2024.117610.
    PubMed     Abstract available
    
    
    
59. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
    Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
    Atherosclerosis. 2024;393:117558.
    PubMed     Abstract available
    
    
    
60. GOUDA P, Islam S, Dover DC, Kaul P, et al
    Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
    Atherosclerosis. 2024;393:117477.
    PubMed     Abstract available
    
    
    
61. MASROURI S, Tamehri Zadeh SS, Shapiro MD, Khalili D, et al
    Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
    Atherosclerosis. 2024;393:117520.
    PubMed     Abstract available
    
    
    
62. WELSH RC, Gouda P, Dover D, Bainey KR, et al
    Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease.
    Atherosclerosis. 2024;393:117486.
    PubMed     Abstract available
    
    
    May 2024
63. PINXTERHUIS TH, Ploumen EH, van Vliet D, Gert van Houwelingen K, et al
    Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
    Atherosclerosis. 2024;392:117488.
    PubMed     Abstract available
    
    
    
64. JAIN V, Rifai MA, Kanaya AM, Shah NS, et al
    Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2024;392:117522.
    PubMed     Abstract available
    
    
    
65. SUGANE H, Asaumi Y, Ogata S, Kimura M, et al
    Evaluation of fractional flow reserve and atherosclerotic plaque characteristics on coronary non-contrast T1-weighted magnetic resonance imaging.
    Atherosclerosis. 2024;392:117530.
    PubMed     Abstract available
    
    
    
66. BERLOT AA, Fu X, Shea MK, Tracy R, et al
    Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2024;392:117505.
    PubMed     Abstract available
    
    
    
67. LARSSON J, Auscher S, Pararajasingam G, Heinsen LJ, et al
    Reply to: "Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition".
    Atherosclerosis. 2024;392:117524.
    PubMed    
    
    
    
68. RAZAVI AC, Raggi P, Whelton SP
    Coronary artery calcium: The canary in the coal mine.
    Atherosclerosis. 2024;392:117499.
    PubMed    
    
    
    
69. BUGIARDINI R, Gulati M
    Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.
    Atherosclerosis. 2024;392:117500.
    PubMed     Abstract available
    
    
    
70. BERISHA-MUHARREMI V, Majnaric-Trtica L, Mujaj B
    Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition.
    Atherosclerosis. 2024;392:117484.
    PubMed    
    
    
    April 2024
71. ENGEBRETSEN I, Bugge C, Stovring H, Husebye E, et al
    Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
    Atherosclerosis. 2024;393:117550.
    PubMed     Abstract available
    
    
    
72. XIAO J, Wei H, Gao Z, Chen L, et al
    Differential age-specific associations of LDL cholesterol and body mass index with coronary heart disease.
    Atherosclerosis. 2024;393:117542.
    PubMed     Abstract available
    
    
    
73. GAGNON E, Arsenault BJ
    Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
    Atherosclerosis. 2024;391:117501.
    PubMed     Abstract available
    
    
    
74. HAN Y, Ren L, Fei X, Wang J, et al
    Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
    Atherosclerosis. 2024;391:117471.
    PubMed     Abstract available
    
    
    
75. RINALDI R, Colucci M, Torre I, Ausiello D, et al
    Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
    Atherosclerosis. 2024;391:117503.
    PubMed     Abstract available
    
    
    March 2024
76. MELNES T, Bogsrud MP, Christensen JJ, Rundblad A, et al
    Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
    Atherosclerosis. 2024;392:117507.
    PubMed     Abstract available
    
    
    
77. ESCATE R, Padro T, Perez de Isla L, Fuentes F, et al
    Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
    Atherosclerosis. 2024;392:117502.
    PubMed     Abstract available
    
    
    
78. REXHAJ E, Bar S, Soria R, Ueki Y, et al
    Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
    Atherosclerosis. 2024;392:117504.
    PubMed     Abstract available
    
    
    
79. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
    Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
    Atherosclerosis. 2024;390:117459.
    PubMed     Abstract available
    
    
    
80. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
    Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
    Atherosclerosis. 2024;390:117469.
    PubMed     Abstract available
    
    
    
81. SCHLEGEL A
    Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
    Atherosclerosis. 2024;390:117460.
    PubMed    
    
    
    
82. CHEDID G, Malik A, Daher R, Welty FK, et al
    Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
    Atherosclerosis. 2024;390:117452.
    PubMed    
    
    
    
83. KHAN SU, Al-Mallah MH
    Air pollution and acute coronary syndrome: The air we breathe.
    Atherosclerosis. 2024;390:117453.
    PubMed    
    
    
    
84. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
    Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
    Atherosclerosis. 2024;390:117449.
    PubMed     Abstract available
    
    
    
85. CENKO E, Manfrini O, Bugiardini R
    Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
    Atherosclerosis. 2024;390:117434.
    PubMed    
    
    
    
86. ASMARIAN N, Raeisi Shahraki H
    Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
    Atherosclerosis. 2024;390:117426.
    PubMed    
    
    
    
87. RINALDI R, Russo M, Bonanni A, Camilli M, et al
    Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
    Atherosclerosis. 2024;390:117393.
    PubMed     Abstract available
    
    
    February 2024
88. OBISESAN OH, Boakye E, Wang FM, Dardari Z, et al
    Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2024 Feb 13:117475. doi: 10.1016/j.atherosclerosis.2024.117475.
    PubMed     Abstract available
    
    
    December 2023
89. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
    Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
    Atherosclerosis. 2023;390:117432.
    PubMed     Abstract available
    
    
    
90. ZHANG D, Li P, Qiu M, Liang Z, et al
    Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
    Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
    PubMed     Abstract available
    
    
    September 2023
91. JONAS M, Genereux P, Maehara A, Ben-Yehuda O, et al
    Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial.
    Atherosclerosis. 2023 Sep 3:117264. doi: 10.1016/j.atherosclerosis.2023.117264.
    PubMed     Abstract available
    
    
    August 2023
92. TIAN P, Liu Y, Wang J, Xing L, et al
    Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes.
    Atherosclerosis. 2023 Aug 18:117242. doi: 10.1016/j.atherosclerosis.2023.117242.
    PubMed     Abstract available
    
    
    July 2023
93. BARFOROSHI S, Manubolu VS, Wang R, McClelland RL, et al
    Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2023 Jul 6:117186. doi: 10.1016/j.atherosclerosis.2023.117186.
    PubMed     Abstract available
    
    
    June 2023
94. NIELSEN S, Nyvad J, Christensen KL, Poulsen PL, et al
    Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
    Atherosclerosis. 2023 Jun 29:117170. doi: 10.1016/j.atherosclerosis.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.